Treanda

NDA 22303, held by Cephalon. Bendamustine Hydrochloride.

As of Nov 13, 2026, NDA 22303 (Treanda), held by Cephalon, was first approved by FDA on Oct 31, 2008, with 0 approved supplements and 0 published complete response letters.

• First approved: Oct 31, 2008
• Review: Standard
• Supplements approved: 0
• Complete response letters: 0

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters